Global Cell
Isolation/Separation market report offers
the latest industry trends, technological alteration and forecast data. A
deep-dive view of Diabetic Food Products industry based on its size, growth,
development plans, and opportunities is offered by this report. The forecast
information, SWOT analysis, Diabetic Food Products barriers, and feasibility
study are the vital aspects evaluated in this report.
Industry Insights
The global cell isolation/
separation market size was estimated at USD 3.6 billion in 2016. There has been
a recent increase in the use of the cell isolation in the stem cells research
and cancer studies by the biotechnology companies and pharmaceuticals. This has
triggered immense demand for related products. The cell separation is used for
advanced analytical procedures in cancer and stem cells research. This has
resulted in high demand for proteins and in turn is expected to support the
cell isolation market during the forecast period.
Personalized medicine is
customized medical treatment for each individual which facilitates greater
outcomes. The cell isolation market procedures can be used for personalized
medicine for the early detection of the diseases and to provide proper
treatment. The separation of different cell types is a vital step for research,
diagnostics, biomedical, and biotechnological applications. Thus, the rising
demand for personalized medicine is a major factor augmenting the cell
separation products.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/cell-isolation-separation-market/request-sample
Product Insights
The product segment is
fragmented into consumables and instruments. The consumables segment is
estimated to account for the largest market share. The increase in investment
in research and development activities by the biotech companies has led to a
boost in the cell separation products. This has led to a surge in demand of the
cell separation consumables adding to the segment growth.
The instruments segment is
projected grow at a significant rate due to product development and advancement
during the forecast period. This advancement is helpful in the efficient cell
separation and diagnostics purposes. The increasing incidence of diseases is
responsible for the rise in demand for therapeutics which in turn is adds to
the growth of the separation products.
Application Insights
The biomolecule segment is
reported to have the highest revenue share in 2016. The increasing focus on the
production of the biopharmaceuticals such as monoclonal antibodies,
biosimilars, and proteins add to the segment growth. Moreover, the increasing
research investments and government funding has propelled the sector growth.
The cancer and stem cells
research segment are expected to exhibit rapid growth in the forecast period.
The growing investments made by the pharmaceutical companies in stem cells
research is a major factor responsible for the growth of the segment.
Investments are expected to yield newer products in the research process,
ultimately increasing the demand for the novel and efficient techniques used in
stem cells research adding to the market growth.
End User Insights
The end users segment is
further categorized into research laboratories, institutes, and biotechnology
& biopharmaceutical companies. The research laboratories and institutes
segment accounted for the largest market share in 2016. This is due to the
increased prevalence of the stem cells and cancer research.
The biopharmaceutical &
biotechnology companies segment accounted for remarkable revenue share in the
market. This is due to an increase in the R&D investment by biologics
manufacturers for research activities related to protein therapeutics,
monoclonal antibody, and cancer & stem cells research, which is expected to
boost the demand for cell isolation products.
Regional Insights
North America accounted for
the largest market share in the 2016. Presence of major biotechnology companies
and pharmaceutical companies in the region as well as highly developed
infrastructure has contributed to the growth of the regional sector. In
addition, product advancements and drug discoveries in the region is further
anticipated to boost growth.
Several biotechnology and
pharmaceutical companies are penetrating the Asia Pacific region owing to high
target population base, increasing disposable incomes, cheap labor, and rapidly
growing economy. With highly populated countries, offer a large gene pool for
more research thus. further helping the cell isolation market in the region.
Moreover, there are less stringent regulations along with the availability of
the skilled but cheap worker which add to the market growth.
Competitive Insights
Some of the key players in
the market are BD Biosciences; Thermo Fisher Scientific, Inc.; Merck KGaA;
Beckman Coulter, Inc.; GE Healthcare; STEMCELL Technologies Inc.; Terumo BCT;
and Bio-Rad Laboratories, Inc. The increasing merger, acquisition, and
collaboration between the companies have profited the cell isolation market
growth. For instance, In August 2016, STEMCELL Technologies Inc. and GE
Healthcare announced a licensing agreement. According to which STEMCELL
Technologies’ T-Cell reagents will be commercialize by GE Healthcare. This
reagent can be used for the separation, culture, and activation of T-cells in
clinical applications. Moreover, the newer product launch and regional
expansion have also attributed to the market growth.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment